Tiziana Life Sciences Plc TLSA

NAS: TLSA | ISIN: US88875G1013 15/04/2026

1,330 USD (+3,10%)

(+3,10%) 15/04/2026

Toon enkel gratis nieuws

16 april 2026 · Tiziana Life Sciences Announces Publication of Positive Data Demonstrating Intranasal Anti-CD3 Antibody Attenuates Long COVID Neuroinflammation and Improves Cognitive Function · Persbericht

14 april 2026 · Tiziana Life Sciences Announces Late Breaking Poster Accepted for Presentation at the 7th World Parkinson Congress · Persbericht

1 april 2026 · Tiziana Announces Data Showing Nasal Anti-CD3 Improves Cognition Associated with Aging · Persbericht

25 februari 2026 · Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA · Persbericht

20 januari 2026 · Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab · Persbericht

16 januari 2026 · Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares · Persbericht

16 januari 2026 · Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe